When does Siemens Healthineers report earnings and how will that affect SHL.DE stock?

Earnings are scheduled for **05 Feb 2026**. The report could move SHL.DE stock sharply if management revises guidance, shows margin improvement, or details order trends in Imaging and Varian.

What valuation metrics matter for SHL.DE stock now?

Key metrics: **PE 22.07**, **EPS €1.91**, price to sales **2.02**, and free cash flow per share **€2.03**. Compare these to the sector PE of **33.39** for context.

What is Meyka AI's stance on SHL.DE stock?

Meyka AI rates SHL.DE **69.34/100 (B) - HOLD**. The grade weighs benchmark and sector comparison, growth, key metrics, forecasts, and consensus. Grades are not guaranteed and are not financial advice.

What upside does Meyka AI forecast for SHL.DE stock?

Meyka AI's forecast model projects **€47.33** one year out, implying about **12.29%** upside from the after‑hours price of **€42.15**. Forecasts are model-based projections and not guarantees.

DE Stocks

SHL.DE Siemens Healthineers (XETRA) €42.15 AH 04 Feb 2026: earnings may reset

ByHuzaifa Zahoor February 4, 2026February 4, 2026

SHL.DE stock trades at €42.15 after hours on XETRA as Siemens Healthineers prepares to report results on 05 Feb 2026. Investors are watching revenue mix across Imaging, Diagnostics, Varian and Advanced Therapies ahead of the print. The share price sits below the 50‑day average of €44.20 and well under the year high of €58.48, while market participants monitor volumes of 1,205,531 and a market cap near €47.27 billion.